Orexin A human, rat, mouse, >=97% (HPLC)

Amino Acid Sequence

Glp-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH2 [Disulfide Bridges: 6-12; 7-14]

Application

Orexin A human, rat, mouse has been used to study its effect on the functioning of porcine pancreatic islets. It has also been used as an orexin receptor 1 (OX1R) antagonist to study the effect of orexin systems in the effect of etonogestrel on respiratory response to prolonged metabolic acidosis.

Orexin A has been used to study its effect on serum luteinizing hormone (LH) concentration in lateral ventricle in ovariectomized (OVX) gilts and is used to study the behavioral and metabolic effects of central injections of orexin A on pigeons (Columba livia).

Biochem/physiol Actions

Orexins plays a vital role in several physiological functions including feeding, neuroendocrine regulation and arousal. In addition to this, it is also associated with the pathophysiology of narcolepsy. Orexin A, expressed in locus coeruleus (LC) area, binds to orexin-1 (OX1) receptor and regulates rapid eye movement (REM) sleep by acting on the firing rate of noradrenergic neurons. Orexin A release is regulated by suprachiasmatic nucleus (SCN).

Orexins (hypocretins) comprise a family of hypothalamic peptides that are involved in the initiation of sleep and in feeding behavior. Orexin A stimulates food intake through activation of the OX1 receptor. Orexin B activates OX2 receptors. Both OX1 and OX2 receptors are involved in maintaining arousal. OX2 receptors appear to be inhibitory autoreceptors on orexin-containing neurons.

General description

Orexin A, also known as hypocretin 1 (hcrt1), is a 33 amino acid excitatory neuropeptide, localized in a small set of neurons in the perifornical area of the hypothalamus. It is synthesized from the precursor protein prepro-orexin in neurons. Orexin A binds to its G-protein-coupled receptor orexin-1 (OX1) which is also called as hcrt receptors 1 (hcrtr1).

Orexin A is characterized with an N-terminalpyroglutamyl residue, two intramoleculardisulfidebridges and a C-terminalamidation.

Other Notes

Lyophilized from 0.1% TFA in H2O

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3591917 Orexin A human, rat, mouse, >=97% (HPLC) 200 OFNHNCAUVYOTPM-IIIOAANCSA-N 1S/C152H243N47O44S4/c1-20-76(14)118(146(239)188-96(51-74(10)11)138(231)197-119(80(18)201)147(240)180-92(121(156)214)47-70(2)3)195-115(209)62-166-123(216)78(16) SIGMA-ALDRICH water: 1.00-1.04 mg/mL, clear, colorless, 1% acetic acid: 1.00-1.04 mg/mL, clear, colorless powder ≥97% (HPLC)
£508.39 (exc VAT) per EACH
-
+
3591918 Orexin A human, rat, mouse, >=97% (HPLC) 200 OFNHNCAUVYOTPM-IIIOAANCSA-N 1S/C152H243N47O44S4/c1-20-76(14)118(146(239)188-96(51-74(10)11)138(231)197-119(80(18)201)147(240)180-92(121(156)214)47-70(2)3)195-115(209)62-166-123(216)78(16) SIGMA-ALDRICH water: 1.00-1.04 mg/mL, clear, colorless, 1% acetic acid: 1.00-1.04 mg/mL, clear, colorless powder ≥97% (HPLC)
Click Add to Quote for price and delivery
-
+